Literature DB >> 18355887

Functional hierarchy of two L domains in porcine endogenous retrovirus (PERV) that influence release and infectivity.

Katherine T Marcucci1, Yuri Martina, Frank Harrison, Carolyn A Wilson, Daniel R Salomon.   

Abstract

The porcine endogenous retrovirus (PERV) Gag protein contains two late (L) domain motifs, PPPY and P(F/S)AP. Using viral release assays we demonstrate that PPPY is the dominant L domain involved in PERV release. PFAP represents a novel retroviral L domain variant and is defined by abnormal viral assembly phenotypes visualized by electron microscopy and attenuation of early PERV release as measured by viral genomes. PSAP is functionally dominant over PFAP in early PERV release. PSAP virions are 3.5-fold more infectious in vitro by TCID(50) and in vivo results in more RNA positive tissues and higher levels of proviral DNA using our human PERV-A receptor (HuPAR-2) transgenic mouse model [Martina, Y., Marcucci, K.T., Cherqui, S., Szabo, A., Drysdale, T., Srinivisan, U., Wilson, C.A., Patience, C., Salomon, D.R., 2006. Mice transgenic for a human porcine endogenous retrovirus receptor are susceptible to productive viral infection. J. Virol. 80 (7), 3135-3146]. The functional hierarchies displayed by PERV L domains, demonstrates that L domain selection in viral evolution exists to promote efficient viral assembly, release and infectivity in the virus-host context.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18355887      PMCID: PMC2626135          DOI: 10.1016/j.virol.2008.02.017

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  46 in total

1.  HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress.

Authors:  J Martin-Serrano; T Zang; P D Bieniasz
Journal:  Nat Med       Date:  2001-12       Impact factor: 53.440

2.  Extended analysis of the in vitro tropism of porcine endogenous retrovirus.

Authors:  C A Wilson; S Wong; M VanBrocklin; M J Federspiel
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Changes in viral protein function that accompany retroviral endogenization.

Authors:  Nidia M Oliveira; Harshita Satija; I Arlette Kouwenhoven; Maribeth V Eiden
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-24       Impact factor: 11.205

4.  Infection by porcine endogenous retrovirus after islet xenotransplantation in SCID mice.

Authors:  L J van der Laan; C Lockey; B C Griffeth; F S Frasier; C A Wilson; D E Onions; B J Hering; Z Long; E Otto; B E Torbett; D R Salomon
Journal:  Nature       Date:  2000-09-07       Impact factor: 49.962

5.  Infectivity of Moloney murine leukemia virus defective in late assembly events is restored by late assembly domains of other retroviruses.

Authors:  B Yuan; S Campbell; E Bacharach; A Rein; S P Goff
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

6.  The late domain of human immunodeficiency virus type 1 p6 promotes virus release in a cell type-dependent manner.

Authors:  Dimiter G Demirov; Jan M Orenstein; Eric O Freed
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

7.  Proteins related to the Nedd4 family of ubiquitin protein ligases interact with the L domain of Rous sarcoma virus and are required for gag budding from cells.

Authors:  A Kikonyogo; F Bouamr; M L Vana; Y Xiang; A Aiyar; C Carter; J Leis
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-18       Impact factor: 11.205

8.  Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag).

Authors:  L VerPlank; F Bouamr; T J LaGrassa; B Agresta; A Kikonyogo; J Leis; C A Carter
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-26       Impact factor: 11.205

9.  Productive infection of primary human endothelial cells by pig endogenous retrovirus (PERV).

Authors:  U Martin; M E Winkler; M Id; H Radeke; L Arseniev; Y Takeuchi; A R Simon; C Patience; A Haverich; G Steinhoff
Journal:  Xenotransplantation       Date:  2000-05       Impact factor: 3.907

10.  Production of alpha-1,3-galactosyltransferase null pigs by means of nuclear transfer with fibroblasts bearing loss of heterozygosity mutations.

Authors:  Donna Kolber-Simonds; Liangxue Lai; Steven R Watt; Maria Denaro; Scott Arn; Monica L Augenstein; Jeffery Betthauser; David B Carter; Julia L Greenstein; Yanhong Hao; Gi-Sun Im; Zhonghua Liu; Greg D Mell; Clifton N Murphy; Kwang-Wook Park; August Rieke; David J J Ryan; David H Sachs; Erik J Forsberg; Randall S Prather; Robert J Hawley
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-03       Impact factor: 11.205

View more
  6 in total

1.  An LYPSL late domain in the gag protein contributes to the efficient release and replication of Rous sarcoma virus.

Authors:  Kari A Dilley; Devon Gregory; Marc C Johnson; Volker M Vogt
Journal:  J Virol       Date:  2010-04-14       Impact factor: 5.103

2.  Encephalomyocarditis virus 2A protein is required for viral pathogenesis and inhibition of apoptosis.

Authors:  M Carocci; N Cordonnier; H Huet; A Romey; A Relmy; K Gorna; S Blaise-Boisseau; S Zientara; L Bakkali Kassimi
Journal:  J Virol       Date:  2011-08-17       Impact factor: 5.103

Review 3.  Infection barriers to successful xenotransplantation focusing on porcine endogenous retroviruses.

Authors:  Joachim Denner; Ralf R Tönjes
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

4.  Basal budding and replication of the murine leukemia virus are independent of the gag L domains.

Authors:  Yosef Sabo; Nihay Laham-Karam; Eran Bacharach
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

Review 5.  Importance of Viral Late Domains in Budding and Release of Enveloped RNA Viruses.

Authors:  Lisa Welker; Jean-Christophe Paillart; Serena Bernacchi
Journal:  Viruses       Date:  2021-08-06       Impact factor: 5.048

Review 6.  Porcine Endogenous Retrovirus (PERV) - Molecular Structure and Replication Strategy in the Context of Retroviral Infection Risk of Human Cells.

Authors:  Krzysztof Łopata; Emilia Wojdas; Roman Nowak; Paweł Łopata; Urszula Mazurek
Journal:  Front Microbiol       Date:  2018-04-11       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.